Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption

Journal of Virus Eradication(2023)10.1016/j.jve.2023.100331Source: DataRank Database

HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption is a research paper published in Journal of Virus Eradication (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.17)OA: goldTopics (26)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Gail E. Henderson ORCID,Carol E. Golin ORCID,Kriste Kuczynski,Nuchanart Ormsby,Holly L. Peay ORCID

Live enrichment

PubMed:37416088 PMC:PMC10319831 OpenAlex:https://openalex.org/W4380989724

NIMH NIH HHS

Grant: R34 MH123328

NIAID NIH HHS

Grant: P30 AI050410

National Institutes of Health

Grant: 5R34MH123328-02

Decision Support for Early-Phase HIV Remission Trials

National Institutes of Health

Grant: 5P30AI050410-05

UNC Center for Aids Research

FWCI

0.17

Citation Percentile

0.5%

Citation Trend

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.jve.2023.100331

publisherhttps://doi.org/10.1016/j.jve.2023.100331

publisherhttps://api.elsevier.com/content/article/PII:S2055664023000171?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2055664023000171?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37416088

Fields of Study

HIV/AIDS Research and InterventionsHIV Research and TreatmentHIV/AIDS drug development and treatment0303 health sciences03 medical and health sciences

Keywords

MedicinePsychological interventionClinical trialTransmission (telecommunications)Human immunodeficiency virus (HIV)RespondentRandomized controlled trialFamily medicineInternal medicinePsychiatryHiv CureFixed DurationAnalytic Treatment InterruptionHiv Remission TrialsTime To ReboundTransmission To Sexual PartnersPublic aspects of medicineRA1-1270MicrobiologyQR1-502Original Research

Sustainable Development Goals

SDG 0: Good health and well-being